DPP-4

DPP-4 is dipeptidyl peptidase-4, an enzyme that clips two amino acids from the front of natural GLP-1 and rapidly shuts down its signal. That is why native GLP-1 lasts roughly two minutes in circulation, while drugs such as semaglutide are redesigned to resist the cut and remain available much longer.

What does DPP-4 mean?

DPP-4 meaning is less intimidating once the name is unpacked: dipeptidyl peptidase-4 is a protein-cutting enzyme, also called DPP-IV or CD26. “Dipeptidyl” means two amino acids; “peptidase” means an enzyme that cuts peptides. DPP-4 removes a two-amino-acid piece from susceptible peptides, including the incretin hormone GLP-1.

For GLP-1, the cut changes active GLP-1(7–36) into GLP-1(9–36), which has far less activity at the GLP-1 receptor. A human study found that this shortened metabolite accounted for most measured GLP-1 after administration.

Why doesn’t natural GLP-1 work as a practical drug?

Why doesn’t natural GLP-1 work as a conventional injection? DPP-4 starts dismantling the active hormone almost as soon as it reaches the blood, and the kidneys help clear what remains. In a human pharmacokinetic study, intact GLP-1 was eliminated on roughly a two-minute timescale in both healthy participants and people with type 2 diabetes.

Natural GLP-1 can produce real biological effects during a controlled infusion. The problem is duration, not whether the hormone works. A useful medicine cannot require a fresh dose every few minutes. The GLP-1 peptide hub follows the engineered answers to that problem.

How is semaglutide DPP-4 resistant?

Semaglutide is DPP-4 resistant because alanine at position 8, beside DPP-4’s cutting site, is replaced with alpha-aminoisobutyric acid (Aib). The semaglutide discovery paper identifies that Aib8 substitution; the current DailyMed label confirms that position 8 stabilizes semaglutide against DPP-4 degradation.

That substitution blocks the enzyme’s easy cut, but it is only half the trick. Semaglutide also uses lipidation, attaching a fatty chain that binds albumin. Albumin acts like a slow-moving carrier, reducing kidney clearance and shielding the peptide from breakdown. The peptide glossary separates those two jobs: DPP-4 resistance protects the vulnerable end; lipidation keeps the drug circulating.

Is DPP-4 the same as a DPP-4 inhibitor?

DPP-4 is the enzyme; a DPP-4 inhibitor is a drug that blocks that enzyme. These drugs protect some of the body’s own GLP-1 rather than supplying a long-acting GLP-1 copy. Semaglutide takes the opposite engineering route: leave DPP-4 alone, but give the enzyme a target it cannot clip easily. Same bottleneck, different workaround.